This inventor holds 25 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Nucleotide Chemistry. Top assignees: Gilead Sciences, Inc., Isis Pharmaceuticals, Inc., Other. Active years: 1978-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Los Alamitos, CA (US) (1978)
- Daly City, CA (US) (1996 - 2002)
- Millbrae, CA (US) (1996 - 2008)
Company Filing History:
15 out of 946 
9 out of 1,035 
1 out of 834,570 Years Active: 1978-2008
Areas of Expertise:
Title: Robert J. Jones: Innovator in Nucleotide Analog Research
Introduction
Robert J. Jones, based in Millbrae, California, is a prolific inventor with 24 patents to his name. His groundbreaking work primarily focuses on advancements in nucleotide analogs and their applications in pharmaceutical science.
Latest Patents
One of his latest contributions involves the development of nucleotide analogs characterized by the presence of an amidate linked amino acid or an ester linked group bonded to the phosphorus atom of phosphonate nucleotide analogs. These analogs feature a phosphoamidate or ester bond that is hydrolyzed in vivo to produce a corresponding phosphonate nucleotide analog. Additionally, he has patented innovative oligomers that demonstrate enhanced triple-helix and double-helix formation compared to those containing only conventional bases. These novel oligomers can form triplexes with various target sequences, such as those from viruses or oncogenes, and are effectively used in pharmaceutical applications to treat viral diseases and for diagnostic purposes.
Career Highlights
Throughout his career, Robert J. Jones has made significant strides in the field of molecular biology and biochemistry. His experience includes working with renowned companies such as Gilead Sciences, Inc. and Isis Pharmaceuticals, Inc., where he contributed to various innovative projects aimed at improving therapeutic methods.
Collaborations
Collaboration has played an essential role in Jones' career, with notable coworkers such as Mark D. Matteucci and Jeff Pudlo. These partnerships have facilitated the exchange of ideas and the advancement of cutting-edge research in nucleotide analogs and their potential applications.
Conclusion
Robert J. Jones stands out as a forward-thinking inventor whose 24 patents reflect his dedication to innovation in the field of nucleotide research. His latest patents not only contribute to the understanding of molecular biology but also pave the way for new treatment options for diseases caused by genetic conditions and viruses. His continued work promises to have a lasting impact on pharmaceutical science and diagnostic methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile